Skip to main content
. 2022 Nov 22;14(12):2561. doi: 10.3390/pharmaceutics14122561
5-FU 5-fluorouracil
ALCL anaplastic large cell lymphoma
Apt aptamer
ATP adenosine triphosphate
AuNPs gold nanoparticles
CD133 differentiation antigen 133
CLPs cationic liposomes
CRC colorectal cancer
CSCs cancer stem cells
CTCs circulating tumor cells
DOX doxorubicin
DTNs DNA tetrahedron nanostructures
DTX docetaxel
EGFR epidermal growth factor receptor
EpCAM epithelial cell adhesion molecule
EPI epirubicin
FITC fluorescein isothiocyanate
G4 G-tetramer
GSH glutathione
HCC hepatocellular carcinoma
HPMA N-(2-hydroxypropyl) methylacrylamide
JNPs janus nanoparticles
MNPs magnetic nanoparticles
MREs molecular recognition elements
MSNs mesoporous silica nanoparticles
MUC1 mucin 1
MUC16 mucin16
NPs nanoparticles
OXA oxaliplatin
PA pyrochlorophyll A
PAM polyacrylamide
PCR polymerase chain reaction
PEG polyethylene glycolpegylated
PEI polyetherimide
PLGA poly(lactic-co-glycolic acid)
PMA phorbol-12-myristate-13-acetate
PTX paclitaxel
QDs quantum dots
ROS reactive oxygen species
SELEX exponential enrichment
siBraf anti-BRAF siRNA
SLNs solid lipid nanoparticles
ssRNA partial complementary paired RNA
TFO triplex forming oligonucleotides
TME tumor microenvironment
TNBC triple-negative breast cancer
TSIIA tanshinone II-A
VEGF vascular endothelial growth factor